Cosmos Labs wants to redesign ATOM after its existing model failed to capture value from widespread use of its open-source software. The effort marks a pivot away from its Interchain Security model, ...

Please join the CSIS Project on Nuclear Issues (PONI) on Wednesday, December 10, 2025 at 9:00 am ET, for the launch of its report, Project Atom 2025. Attendance for the full day is not required. The ...

A team from the Faculty of Physics and the Center for Quantum Optical Technologies at the Center of New Technologies, University of Warsaw has developed a new method for measuring elusive terahertz ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

When former Twitter CEO Dick Costolo spoke at TechCrunch Disrupt, someone from the audience asked him if HBO’s hit satire “Silicon Valley” would be revived. Costolo, who was a writer for the show, ...

The Potensic Atom 2 is a fantastic little drone with some impressive features and good image quality. Some of the features on offer come with caveats, but they're not necessarily deal breakers. Why ...

Abstract: Neutral atom arrays have seen exciting progress as a platform for quantum computation. However, as we move towards the regime of fault-tolerance, the large-scale impact of fundamental ...

Not tunable. Hearing support is very blunt. Not a great value considering the whole package. Audien has repeatedly tried again in this low-end part of the market, cranking out at least five models of ...

For many enterprises, there continue to be barriers to fully adopting and benefiting from agentic AI. IBM is betting the blocker isn't building AI agents but governing them in production. At its ...

A new platform developed by Illinois Grainger engineers demonstrates the utility of a ytterbium-171 atom array in quantum networking. Their work represents a key step toward long-distance quantum ...

Atom Therapeutics is touting data from a phase 2b/3 study as evidence that its gout drug has the efficacy and safety profile to stand out from the competition. The Chinese biotech evaluated the oral ...